Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study (Q39499020)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study |
scientific article |
Statements
1 reference
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study (English)
1 reference
1 reference
Jeanne M Schilder
1 reference
Carol Aghajanian
1 reference
Edwin A Alvarez
1 reference
William E Brady
1 reference
Joan L Walker
1 reference
Jacob Rotmensch
1 reference
Xun C Zhou
1 reference
James E Kendrick
1 reference
S Diane Yamada
1 reference
Charles R Harrison
1 reference
Kathleen N Moore
1 reference
20 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference